Jose D. Herazo-Maya
Jose D. Herazo-Maya
Associate Professor, University of South Florida
Verified email at usf.edu
Title
Cited by
Cited by
Year
PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis
M Bueno, YC Lai, Y Romero, J Brands, CMS Croix, C Kamga, C Corey, ...
The Journal of clinical investigation 125 (2), 521-538, 2015
2752015
Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis
JD Herazo-Maya, I Noth, SR Duncan, SH Kim, SF Ma, GC Tseng, ...
Science translational medicine 5 (205), 205ra136-205ra136, 2013
2022013
Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function
G Yu, A Tzouvelekis, R Wang, JD Herazo-Maya, GH Ibarra, A Srivastava, ...
Nature medicine 24 (1), 39, 2018
1212018
Wnt coreceptor Lrp5 is a driver of idiopathic pulmonary fibrosis
AP Lam, JD Herazo-Maya, JA Sennello, AS Flozak, S Russell, GM Mutlu, ...
American journal of respiratory and critical care medicine 190 (2), 185-195, 2014
882014
PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production
LJ Celada, JA Kropski, JD Herazo-Maya, W Luo, A Creecy, AT Abad, ...
Science translational medicine 10 (460), 2018
812018
Extracellular mitochondrial DNA is generated by fibroblasts and predicts death in idiopathic pulmonary fibrosis
C Ryu, H Sun, M Gulati, JD Herazo-Maya, Y Chen, A Osafo-Addo, ...
American journal of respiratory and critical care medicine 196 (12), 1571-1581, 2017
802017
Blockade of the programmed death-1 pathway restores sarcoidosis CD4+ T-cell proliferative capacity
NA Braun, LJ Celada, JD Herazo-Maya, S Abraham, G Shaginurova, ...
American journal of respiratory and critical care medicine 190 (5), 560-571, 2014
722014
Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study
JD Herazo-Maya, J Sun, PL Molyneaux, Q Li, JA Villalba, A Tzouvelekis, ...
The Lancet Respiratory Medicine 5 (11), 857-868, 2017
602017
Validation of the prognostic value of MMP‐7 in idiopathic pulmonary fibrosis
A Tzouvelekis, JD Herazo‐Maya, M Slade, J Chu, G Deiuliis, C Ryu, Q Li, ...
Respirology 22 (3), 486-493, 2017
522017
Integrative phenotyping framework (iPF): integrative clustering of multiple omics data identifies novel lung disease subphenotypes
SH Kim, JD Herazo-Maya, DD Kang, BM Juan-Guardela, J Tedrow, ...
BMC genomics 16 (1), 1-11, 2015
502015
Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study
MKD Scott, K Quinn, Q Li, R Carroll, H Warsinske, F Vallania, S Chen, ...
The Lancet Respiratory Medicine 7 (6), 497-508, 2019
432019
Matrix Metalloproteinase-19 Promotes Metastatic Behavior In Vitro and Is Associated with Increased Mortality in Non–Small Cell Lung Cancer
G Yu, JD Herazo-Maya, T Nukui, M Romkes, A Parwani, ...
American journal of respiratory and critical care medicine 190 (7), 780-790, 2014
402014
Transcriptional regulatory model of fibrosis progression in the human lung
JE McDonough, F Ahangari, Q Li, S Jain, SE Verleden, J Herazo-Maya, ...
JCI insight 4 (22), 2019
392019
SH2 domain–containing phosphatase-2 is a novel antifibrotic regulator in pulmonary fibrosis
A Tzouvelekis, G Yu, CL Lino Cardenas, JD Herazo-Maya, R Wang, ...
American journal of respiratory and critical care medicine 195 (4), 500-514, 2017
372017
SH2 domain–containing phosphatase-2 is a novel antifibrotic regulator in pulmonary fibrosis
A Tzouvelekis, G Yu, CL Lino Cardenas, JD Herazo-Maya, R Wang, ...
American journal of respiratory and critical care medicine 195 (4), 500-514, 2017
372017
BAL cell gene expression is indicative of outcome and airway basal cell involvement in idiopathic pulmonary fibrosis
A Prasse, H Binder, JC Schupp, G Kayser, E Bargagli, B Jaeger, M Hess, ...
American journal of respiratory and critical care medicine 199 (5), 622-630, 2019
342019
Antifibrotic role of vascular endothelial growth factor in pulmonary fibrosis
LA Murray, DM Habiel, M Hohmann, A Camelo, H Shang, Y Zhou, ...
JCI insight 2 (16), 2017
302017
Biomarkers in the evaluation and management of idiopathic pulmonary fibrosis
A Tzouvelekis, J Herazo-Maya, K Sakamoto, D Bouros
Current topics in medicinal chemistry 16 (14), 1587-1598, 2016
302016
Plexin C1 deficiency permits synaptotagmin 7–mediated macrophage migration and enhances mammalian lung fibrosis
X Peng, M Moore, A Mathur, Y Zhou, H Sun, Y Gan, JD Herazo‐Maya, ...
The FASEB Journal 30 (12), 4056-4070, 2016
282016
A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis
Y Huang, SF Ma, R Vij, JM Oldham, J Herazo-Maya, SM Broderick, ...
BMC pulmonary medicine 15 (1), 1-12, 2015
262015
The system can't perform the operation now. Try again later.
Articles 1–20